ChemoCentryx Inc. | Key People and Executives
Thomas J. Schall
Chairman, President & Chief Executive Officer
Henry K. McKinnell
Independent Director
Thomas A. Edwards
Independent Director
Joseph M. Feczko
Independent Director
Roger C. Lucas
Lead Independent Director
James L. Tyree
Independent Director
Geoffrey M. Parker
Independent Director
Thomas J. Schall
Chairman, President & Chief Executive Officer
William Fairey
Chief Operating Officer & Executive Vice President
Susan M. Kanaya
CFO, Secretary, CAO & Principal Accounting Officer
Rajinder Singh
Senior Vice President-Research
Jan L. Hillson
Senior Vice President-Drug Development
Markus J. Cappel
Treasurer & Chief Business Officer
Stephanie Tomei
Media Contact
Henry K. McKinnell
Independent Director
Thomas A. Edwards
Independent Director
Joseph M. Feczko
Independent Director
Roger C. Lucas
Lead Independent Director
James L. Tyree
Independent Director
Geoffrey M. Parker
Independent Director
| Address |
850 Maude Avenue
Mountain View California 94043
United States
|
|
Employees
|
- |
| Website |
http://www.chemocentryx.com |
| Updated |
07/08/2019 |
| ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. |
